Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT

University Hospital, Bordeaux1,329 enrolled

Overview

Only 5% of patients infected with COVID-19 develop severe or critical Coronavirus disease 2019 (COVID-19) and there is no reliable risk stratification tool for non-severe COVID-19 patients at admission. Finding a way to predict which patients with an initial mild to moderate presentation of COVID-19 would develop severe or critical form of COVID-19 according to CT-scan data, simple clinical and biological parameters is challenging. In this multicentric study, the study aims to construct a predictive score for early identification of cases at high risk of progression to moderate, severe or critical COVID-19 combining simple clinical and biological parameters and qualitative, quantitative or artificial intelligence (AI) data from the initial CT from non-severe patients.

A few numbers of patients infected with Coronavirus disease 2019 (COVID-19) rapidly develop acute respiratory distress leading to respiratory failure, with high short-term mortality rates. However, only 5% of patients infected with COVID-19 are concerned by this pejorative evolution. At present, there is no reliable risk stratification tool for non-severe COVID-19 patients at admission. Chest computed tomography (CT) is widely used for the management of COVID-19 pneumonia because of its availability and quickness. The standard of reference for confirming COVID-19 relies on microbiological tests but these tests might not be available in an emergency setting and their results are not immediately available, contrary to CT. In addition to its role for early diagnosis, CT has a prognostic role through evaluating the extent of COVID-19 lung abnormalities. Finding a way to predict which patients with an initial mild to moderate presentation of COVID-19 would develop severe or critical form of COVID-19 according to CT-scan data, simple clinical and biological parameters is challenging. In this multicentric study, the study aims to construct a predictive score for early identification of cases at high risk of progression to moderate, severe or critical COVID-19 combining simple clinical and biological parameters and qualitative, quantitative or artificial intelligence (AI) data from the initial CT from non-severe patients. The final objective is to organize optimal patient management in the appropriate health structure.

Study Type

OBSERVATIONAL

Enrollment

1,329

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * First chest CT, assessed for respiratory symptoms, without injection of contrast agent for respiratory symptoms, and whose results of the CT subjective visual analysis are compatible or typical of COVID-19 * biological diagnosis of COVID-19 (RT-PCR) or clinical suspicion (cough and / or dyspnea and / or fever and / or need to use oxygen therapy as part of routine care) at the time of the examination * Authorization of the patient for the processing of his personal data, except CNIL exemption Exclusion Criteria: * Patient with a moderate (oxygen between 3 and 5 L / min to achieve saturation greater than 97% and a respiratory rate \<25 / min without the need for invasive ventilation), severe form (oxygen therapy\> 5L / min to obtain a SpO2\> 97%) or critical form (need to resort to ventilation and / or orotracheal intubation) at the date of the first chest CT * Age \< 18 years old * Patient deprived of liberty by judicial decision

Locations (7)

CHU Bordeaux

Bordeaux, France

Clinique Bordeaux Nord

Bordeaux, France

Clinique Saint Augustin

Bordeaux, France

CHU de Grenoble Alpes

Grenoble, France

Hôpital Arnaud-de-Villeneuve CHU de Montpellier

Montpellier, France

Hôpitaux de Brabois CHU de Nancy

Nancy, France

Hôpital de la Milétrie CHU de Poitiers

Poitiers, France

Outcomes

Primary Outcomes

occurrence of significant clinical degradation

The primary outcome is defined by the occurrence of significant clinical degradation within 30 days following the initial chest CT. Significant clinical degradation is defined by the transition from the mild to the moderate form of COVID-19, i.e., according to the WHO criteria, the requirement of oxygen between 3 and 5 L / min to achieve saturation greater than 97% and a respiratory rate \<25 / min without the need for invasive ventilation.